Literature DB >> 18209308

T-helper subsets cytokine production in kidney transplant recipients: diverting influences and impact on graft outcome.

A A Hassan1, M Zaki, M Shoukeir, R Khalil.   

Abstract

UNLABELLED: A large body of evidence suggests the existence of functionally polarized human T-helper responses based on their profile of cytokine secretion. Human T-helper cell clones can be divided into two mutually exclusive subsets, T-helper cell 1 (Th1) and T-helper cell 2 (Th2). Substantial work in several animal models has demonstrated that allograft rejection is associated with enhanced Th1 activity and tolerance with enhanced Th2. Some studies have not been consistent with this association. In this study, gamma interferon (INF-y) and interleukin 4 (IL-4) levels (as indicators of Th1 and Th2 activity, respectively) were assayed in supernatant of cultured peripheral lymphocytes. The levels of these cytokines were compared between a study group of 26 stable kidney transplant recipients immunosuppressed with cyclosporine A, corticosteroids and azathioprine or mycophenolate mofetil, and a control group of 10 healthy blood donors. The mean INF-gamma and IL-4 levels in the control group were considered as the cutoff levels for comparison. Our results showed that 25/26 of the study patients (96%) had low levels of INF-gamma compared to 4/10 of the control subjects (40%), (P< 0.05). However, the IL-4 level was high in 10/26 of the study patients (38%) and 3/10 of the control subjects (30%), not a statistically significant difference, (P>0.05). IN
CONCLUSION: These results suggest that well-established graft tolerance may be mediated via depressed Th1 activity rather than enhanced Th2 activity.

Entities:  

Year:  2000        PMID: 18209308

Source DB:  PubMed          Journal:  Saudi J Kidney Dis Transpl        ISSN: 1319-2442


  1 in total

1.  Immune responses in autoimmune hepatitis: effect of prednisone and azathioprine treatment: case report.

Authors:  Martin H Bluth; Stephan Kohlhoff; Kevin B Norowitz; Jonathan I Silverberg; Seto Chice; M Nowakowski; Helen G Durkin; Tamar A Smith-Norowitz
Journal:  Int J Med Sci       Date:  2009-06-30       Impact factor: 3.738

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.